Abiopharma

🔍 Eaves Patricia (Executive)

Company: FIRST BANCORP /PR/ (FBP)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Sold 209 shares of First BanCorp Common Stock, par value $0.10 per share. at $21.36 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: false | shares_owned_after: 19,779.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,872 shares of First BanCorp Common Stock, par value $0.10 per share. at $21.36 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 21,651.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Shares withheld to cover taxes related to restricted stock that vested on March 31, 2026 pursuant to the terms of the restricted stock award made on March 31, 2025.
• F2: Represents shares of restricted stock issued on March 31, 2026 pursuant to the First BanCorp Omnibus Incentive Plan, as amended, which vest solely on the basis of the passage of time over a one-year period on March 31, 2027.